Advanced Search

Pathology/Lab Coding Alert

Path/Lab Coding:

Know When to Bill for Cellular Enhancement When Examining Breast Aspiration

Published on Tue Jul 28, 2026

Question: Our pathologist performed a fine needle aspiration (FNA) on a patient’s breast, then examined the aspirate using selective cellular enhancement. In addition to billing for the FNA and the evaluation and report of the specimen, can we also bill for the cellular enhancement? Revenue Cycle Insider Subscriber Answer: No, you cannot report 88112 (Cytopathology, selective cellular enhancement technique with [...]
Codify by AAPC
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Pathology/Lab Coding Alert

Subscribe to newsletter